2026-02-09, 2:17:13 p.m.
BETHLEHEM, Pa. — February 9, 2026 — Leads & Copy — OraSure Technologies, Inc. (NASDAQ: OSUR) will hold its earnings conference call covering fourth quarter 2025 financial results and certain business developments at 5 p.m. ET on February 25, 2026.
A webcast of the conference call will be available on the investor relations page of OraSure’s website at https://orasure.gcs-web.com/events-and-presentations. Those interested should click on the webcast link and follow the prompts for registration and access at least 10 minutes prior to the call. The webcast will be archived on OraSure’s website shortly after the call has ended.
OraSure Technologies, Inc. (“OraSure” and “OTI”) aims to transform health through actionable insight and decentralizes diagnostics to connect people to healthcare wherever they are. According to the company, OTI improves access, quality, and value of healthcare with innovation in effortless tests and sample management solutions. Together with its wholly-owned subsidiaries, DNA Genotek Inc., Sherlock Biosciences, Inc., and BioMedomics, Inc., OTI is a leader in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions.
OTI’s portfolio of products is sold globally to clinical laboratories, hospitals, physicians’ offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct to consumers.
Source: OraSure Technologies, Inc.
